[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase
Green Cross MS is showing strong performance.
As of 10:04 AM on the 16th, Green Cross MS is trading at 6,390 KRW on the KOSDAQ market, up 1,310 KRW (25.79%) from the previous trading day.
It is interpreted that the recent sharp increase in the number of patients hospitalized due to COVID-19 is influencing the stock price.
Hot Picks Today
![[Exclusive] "This Is Why Samsung Stands Out"... Onnuri Gift Certificates Replace Loyalty Points](https://cwcontent.asiae.co.kr/asiaresize/93/2026060511022289079_1780624942.jpg)
[Exclusive] "This Is Why Samsung Stands Out"... Onnuri Gift Certificates Replace Loyalty Points
- "Seoul's Nightlife Transformed: Why Fewer People Ride the Subway After Midnight"
- Drunk Man in His 30s Drives 1.5 km Dragging Substitute Driver to Death... Bereaved Family: "No Apology"
- "What Would Those Ignorant People Know? They Won't Notice If We Don't Give Them Ballots"…Drama Scene Resurfaces Amid Ballot Shortage Crisis
- 'Youngest' Koo Kwangmo Fills Water Glasses, 'Eldest' Chey Taewon Pours Drinks... Toast: "Go Korea! SK, LG, Naver"
Green Cross MS was established in 2003 with the business purpose of manufacturing and selling in vitro diagnostic pharmaceuticals and medical devices, as well as manufacturing and selling pharmaceuticals and quasi-drugs.
![[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
The company is composed of three business divisions: diagnostic reagents, hemodialysis solutions, and diabetes. By handling products in various fields together, it supplies to a wide range of customers including public health centers, screening centers, internal medicine clinics, dermatology clinics, plastic surgery clinics, hospitals, general hospitals, and university hospitals, thereby maintaining an extensive domestic sales network.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
